Activation of NFAT signal by p53-K120R mutant

FEBS Letters

Volumn 583, Issue 12, 2009, Pages 1916-1922

  Shinmen, Natsuko ^a,b   Koshida, Toshifumi ^a   Kumazawa, Takeshi ^b   Sato, Keizo ^b   Shimada, Hideaki ^c   Matsutani, Tomoo ^a   Iwadate, Yasuo ^a   Takiguchi, Masaki ^a   Hiwasa, Takaki ^a  

^a CHIBA UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c CHIBA CANCER CENTER   (Japan)

Author keywords

Calcium signal; Luciferase reporter assay; Nuclear factor of activated T cell; p53

Indexed keywords

MUTANT PROTEIN; PROTEIN P53; TRANSCRIPTION FACTOR NFAT;

ACETYLATION; ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; CELL STRAIN HEPG2; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; GLIOBLASTOMA; HUMAN; HUMAN CELL; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN MODIFICATION; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSACTIVATION; WILD TYPE;

ACETYLATION; BINDING SITES; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; GENES, REPORTER; GLIOBLASTOMA; HUMANS; LUCIFERASES; LYSINE; MUTAGENESIS, SITE-DIRECTED; NFATC TRANSCRIPTION FACTORS; PHOSPHORYLATION; POINT MUTATION; PROLINE OXIDASE; RECOMBINANT PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 67349172713     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.04.041     Document Type: Article

References (33)

1. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., and Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 75 (1993) 817-825
2. Miyashita T., and Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80 (1995) 293-299
3. Nakano K., and Vousden K.H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 7 (2001) 683-694
4. Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita T., Tokino T., Taniguchi T., and Tanaka N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288 (2000) 1053-1058
5. Jiang P., Du W., Heese K., and Wu M. The Bad guy cooperates with good cop p53: Bad is transcriptionally up-regulated by p53 and forms a Bad/p53 complex at the mitochondria to induce apoptosis. Mol. Cell Biol. 26 (2006) 9071-9082
6. Olsson A., Manzl X., Strasser A., and Villunger A. How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?. Cell Death Differ. 14 (2007) 1561-1575
7. Rao A., Luo C., and Hogan P.C. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15 (1997) 707-747
8. Rincon M., and Flavell R.A. Transcription mediated by NFAT is highly inducible in effector CD4+ T helper 2 (Th2) cells but not in Th1 cells. Mol. Cell Biol. 17 (1997) 1522-1534
9. Loh C., Shaw K.T., Carew J., Viola J.P., Luo C., Perrino B.A., and Rao A. Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity. J. Biol. Chem. 271 (1996) 10884-10891
10. Crabtree G.R., and Olson E.N. NFAT signaling: choreographing the social lives of cells. Cell 109 Suppl. (1999) S67-S79
11. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., and Vogelstein B. A model for p53-induced apoptosis. Nature 389 (1997) 300-305
12. Maxwell S.A., and Davis G.E. Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines. Proc. Natl. Acad. Sci. USA 97 (2000) 13009-13014
13. Cooper S.K., Pandhare J., Donald S.P., and Phang J.M. A novel function for hydroxyproline oxidase in apoptosis through generation of reactive oxygen species. J. Biol. Chem. 283 (2008) 10485-10492
14. Rivera A., and Maxwell S.A. The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway. J. Biol. Chem. 280 (2005) 29346-29354
15. Liu Y., Borchert G.L., Surazynski A., Hu C.-A., and Phang J.M. Proline oxidase activates both intrinsic and extrinsic pathways for apoptosis: the role of ROS/superoxides, NFAT and MEK/ERK signaling. Oncogene 25 (2006) 5640-5647
16. 2+/calcineurin signaling pathway. EMBO J. 25 (2006) 3714-3724
17. Baker S.J., Markowitz S., Fearon E.R., Willson J.K.V., and Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249 (1990) 912-915
18. Hiwasa T., Sawada T., and Sakiyama S. Cysteine proteinase inhibitors and ras gene products share the same biological activities including transforming activity toward NIH3T3 mouse fibroblasts and the differentiation-inducing activity toward PC12 rat pheochromocytoma cells. Carcinogenesis 11 (1990) 75-80
19. Liu T.-L., Shimada H., Ochiai T., Shiratori T., Lin S.E., Kitagawa M., Harigaya K., Maki M., Oka M., Abe T., Takiguchi M., and Hiwasa T. Enhancement of chemosensitivity toward peplomycin by calpastatin-stabilized NF-κB p65 in esophageal carcinoma cells: possible involvement of Fas/Fas-L synergism. Apoptosis 11 (2006) 1025-1037
20. r-1 cells derived from ultraviolet-sensitive human RSa cells. Cell Death Differ. 7 (2000) 531-537
21. Vassilev L.T., Vu B.T., Graves B., Carvajal D., Podlaski F., Filipovic Z., Kong N., Kammolott U., Lukacs C., Klein C., Fotouhi N., and Liu E.A. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303 (2004) 844-848
22. Haupt Y., Maya R., Kazaz A., and Oren M. Mdm2 promotes the rapid degradation of p53. Nature 387 (1997) 296-299
23. Prives C. Signaling to p53: breaking the MDM2-p53 circuit. Cell 95 (1998) 5-8
24. Kaeser M.D., Pebernard S., and Iggo R.D. Regulation of p53 stability and function in HCT116 colon cancer cells. J. Biol. Chem. 279 (2004) 7598-7605
25. Roth J., Dobbelstein M., Freedman D.A., Shenk T., and Levine A.J. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17 (1998) 554-564
26. Tang Y., Zhao W., Chen Y., Zhao Y., and Gu W. Acetylation is indispensable for p53 activation. Cell 133 (2008) 612-626
27. Sykes S.M., Mellert H.S., Holbert M.A., Li K., Marmorstein R., Lane W.S., and McMahon S.B. Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol. Cell 24 (2006) 841-851
28. Zupnick A., and Prives C. Mutational analysis of the p53 core domain L1 loop. J. Biol. Chem. 281 (2006) 20464-20473
29. Seto E., Usheva A., Zambetti G.P., Momand J., Horikoshi N., Weinmann R., Levine A.J., and Shenk T. Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc. Natl. Acad. Sci. USA 89 (1992) 12028-12032
30. II31 protein is a transcriptional coactivator of the p53 protein. Proc. Natl. Acad. Sci. USA 92 (1995) 5154-5158
31. Gu W., Shi X.L., and Roeder R.G. Synergistic activation of transcription by CBP and p53. Nature 387 (1997) 819-823
32. Batta K., and Kundu T.K. Activation of p53 function by human transcriptional coactivator PC4: role of protein-protein interaction, DNA bending, and posttranslational modifications. Mol. Cell Biol. 27 (2007) 7607-7614
33. Zeng P.Y., and Berger S.L. LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation. Cancer Res. 66 (2006) 10701-10718